Close Menu

NEW YORK – The number of mergers and acquisitions in the molecular diagnostics and omics life science tools space rose 13 percent in 2019, continuing the 12 percent climb from the previous year and putting the 4 percent decline the industry saw in 2017 firmly in the rear-view mirror.

According to an analysis by GenomeWeb, there were 62 deals completed in the MDx/omics tools space in 2019 compared to 55 deals in 2018.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

European regulators have begun a rolling review of Russia's Sputnik V SARS-CoV-2 vaccine, Reuters reports.

Science reports that Science Foundation Ireland is seeking annual budget increases.

According to the Financial Times, a UK university group is pushing Elsevier to lower its journal fees.

In Nature this week: satellite tracking and genome sequencing combination used to examine migration patterns of peregrine falcons, and more.